Evaluation Of Electrocardiographic Repolarization Parameters After Administration Of Trimethoprim-Sulfadiazine, Detomidine, Or Their Combination In Horses

OBJECTIVETo determine whether administration of trimethoprim-sulfadiazine (TMS), detomidine (DET), or TMS plus DET would be associated with changes in ECG repolarization parameters in horses.ANIMALS9 healthy adult horses.PROCEDURESEach horse received 4 treatments in a blinded, randomized, crossover study design as follows: TMS, 16 to 24 mg/kg, IV; DET, 0.015 to 0.02 mg/kg, IV; TMS plus DET; and saline (0.9% NaCl) solution. Surface ECG traces were obtained over 24 hours, and repolarization parameters were measured at predefined time points after each treatment and compared with a 2-way ANOVA for repeated measures.RESULTSHeart rate-corrected QT intervals (QTc) were significantly increased after administration of DET (mean +/- SD difference in QTc, 36.57 +/- 23.07 milliseconds; increase of 7%) and TMS plus DET (44.96 +/- 29.16 milliseconds; increase of 9%), compared with baseline (before treatment) values and values after administration of saline solution. Saline solution and TMS alone did not affect QTc.CONCLUSIONS AND CLINICAL RELEVANCEAdministration of DET or TMS plus DET was associated with a significant and possibly clinically relevant prolongation of QTc, with prolongation of 7% to 9%, a range that is considered as a risk factor for the development of cardiac arrhythmias in people. Results were unexpected because DET is considered to be a safe sedative for horses.